Format
Sort by
Items per page

Send to

Choose Destination

Links from HomoloGene

Items: 1 to 20 of 154

1.

Investigation of FANCA mutations in Greek patients.

Selenti N, Sofocleous C, Kattamis A, Kolialexi A, Kitsiou S, Fryssira E, Polychronopoulou S, Kanavakis E, Mavrou A.

Anticancer Res. 2013 Aug;33(8):3369-74.

PMID:
23898106
2.

Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Litim N, Labrie Y, Desjardins S, Ouellette G, Plourde K, Belleau P; INHERIT BRCAs, Durocher F.

Mol Oncol. 2013 Feb;7(1):85-100. doi: 10.1016/j.molonc.2012.08.002. Epub 2012 Sep 11.

3.

Fanconi anemia complementation group A (FANCA) protein has intrinsic affinity for nucleic acids with preference for single-stranded forms.

Yuan F, Qian L, Zhao X, Liu JY, Song L, D'Urso G, Jain C, Zhang Y.

J Biol Chem. 2012 Feb 10;287(7):4800-7. doi: 10.1074/jbc.M111.315366. Epub 2011 Dec 21.

4.

Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Castella M, Pujol R, Callén E, Trujillo JP, Casado JA, Gille H, Lach FP, Auerbach AD, Schindler D, Benítez J, Porto B, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Torrent M, Estella J, Dasí A, Rodríguez-Villa A, Gómez P, Barbot J, Tapia M, Molinés A, Figuera A, Bueren JA, Surrallés J.

Blood. 2011 Apr 7;117(14):3759-69. doi: 10.1182/blood-2010-08-299917. Epub 2011 Jan 27.

5.

Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.

Solyom S, Winqvist R, Nikkilä J, Rapakko K, Hirvikoski P, Kokkonen H, Pylkäs K.

Cancer Lett. 2011 Mar 28;302(2):113-8. doi: 10.1016/j.canlet.2010.12.020. Epub 2011 Jan 13.

PMID:
21236561
6.

Fanca-/- hematopoietic stem cells demonstrate a mobilization defect which can be overcome by administration of the Rac inhibitor NSC23766.

Milsom MD, Lee AW, Zheng Y, Cancelas JA.

Haematologica. 2009 Jul;94(7):1011-5. doi: 10.3324/haematol.2008.004077. Epub 2009 Jun 2.

7.

Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture.

Hoskins EE, Morris TA, Higginbotham JM, Spardy N, Cha E, Kelly P, Williams DA, Wikenheiser-Brokamp KA, Duensing S, Wells SI.

Oncogene. 2009 Feb 5;28(5):674-85. doi: 10.1038/onc.2008.416. Epub 2008 Nov 17.

8.

[Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].

Chen F, Zhang KJ, Zuo XL, Zeng XC.

Zhonghua Xue Ye Xue Za Zhi. 2007 Nov;28(11):741-4. Chinese.

PMID:
18457264
9.

Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations.

Haiman CA, Hsu C, de Bakker PI, Frasco M, Sheng X, Van Den Berg D, Casagrande JT, Kolonel LN, Le Marchand L, Hankinson SE, Han J, Dunning AM, Pooley KA, Freedman ML, Hunter DJ, Wu AH, Stram DO, Henderson BE.

Hum Mol Genet. 2008 Mar 15;17(6):825-34. Epub 2007 Dec 3.

PMID:
18056155
10.
11.

Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation.

Magdalena N, Pilonetto DV, Bitencourt MA, Pereira NF, Ribeiro RC, Jeng M, Pasquini R.

Braz J Med Biol Res. 2005 May;38(5):669-73. Epub 2005 May 25.

12.

The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells.

Yang YG, Herceg Z, Nakanishi K, Demuth I, Piccoli C, Michelon J, Hildebrand G, Jasin M, Digweed M, Wang ZQ.

Carcinogenesis. 2005 Oct;26(10):1731-40. Epub 2005 May 19.

PMID:
15905196
13.

A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer.

Thompson E, Dragovic RL, Stephenson SA, Eccles DM, Campbell IG, Dobrovic A.

BMC Cancer. 2005 Apr 29;5:43.

14.
15.

Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.

Tischkowitz MD, Morgan NV, Grimwade D, Eddy C, Ball S, Vorechovsky I, Langabeer S, Stöger R, Hodgson SV, Mathew CG.

Leukemia. 2004 Mar;18(3):420-5.

PMID:
14749703
16.

Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.

Lensch MW, Tischkowitz M, Christianson TA, Reifsteck CA, Speckhart SA, Jakobs PM, O'Dwyer ME, Olson SB, Le Beau MM, Hodgson SV, Mathew CG, Larson RA, Bagby GC Jr.

Blood. 2003 Jul 1;102(1):7-16. Epub 2003 Mar 13.

17.

Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool.

Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC, Leurs C, Cooper RJ, Göttsche K, Haneline L, Clapp DW, Lobitz S, Williams DA, Auerbach AD.

Exp Hematol. 2002 May;30(5):410-20.

PMID:
12031647
18.

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

Tipping AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S, Mathew CG.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5734-9.

19.

Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.

Tamary H, Bar-Yam R, Shalmon L, Rachavi G, Krostichevsky M, Elhasid R, Barak Y, Kapelushnik J, Yaniv I, Auerbach AD, Zaizov R.

Br J Haematol. 2000 Oct;111(1):338-43. Erratum in: Br J Haematol 2001 Mar;112(3):829.

PMID:
11091222
20.

Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Joenje H, Levitus M, Waisfisz Q, D'Andrea A, Garcia-Higuera I, Pearson T, van Berkel CG, Rooimans MA, Morgan N, Mathew CG, Arwert F.

Am J Hum Genet. 2000 Sep;67(3):759-62. Epub 2000 Aug 8.

Supplemental Content

Support Center